Skinvisible, Inc. (SKVI)
OTCMKTS · Delayed Price · Currency is USD
0.1700
-0.0320 (-15.84%)
At close: May 7, 2026

Skinvisible Company Description

Skinvisible, Inc. focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas.

Its flagship product, Invisicare, is a patented polymer delivery system technology that enhances the delivery of active ingredients for topically applied skin care products.

The company also offers non-dermatological formulations for women’s health, pain management, and other markets.

In addition, it engages in the development and licensing of topical prescription and over-the-counter products, as well as the co-development of formulations for pharmaceutical clients.

Further, the company provides solutions to pharmaceutical companies by reformulating products coming off patent with a new Invisicare patent, and new product benefits and line extensions.

It has a licensing and collaboration agreement with Ovation Science for the use of Invisicare technology with cannabinoids for topical/transdermal products, including new formulations with THC-V targeting obesity and metabolic health.

The company was formerly known as Microbial Solutions, Inc. and changed its name to Skinvisible, Inc. in February 1999.

Skinvisible, Inc. was incorporated in 1998 and is based in Las Vegas, Nevada.

Skinvisible, Inc.
CountryUnited States
Founded1998
IndustryHousehold & Personal Products
SectorConsumer Staples
Employees2
CEOTerry Howlett

Contact Details

Address:
6320 South Sandhill Road
Las Vegas, Nevada 89120
United States
Phone702 433 7154
Websiteskinvisible.com

Stock Details

Ticker SymbolSKVI
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS8307032032
SIC Code2844

Key Executives

NamePosition
Terry H. HowlettPresident, Chief Executive Officer, Chief Financial Officer and Director
Doreen McMorranHead of Business Development